نمایش پرونده ساده آیتم

dc.contributor.authorBabazadeh, A
dc.contributor.authorZeinali, M
dc.contributor.authorHamishehkar, H
dc.date.accessioned2018-08-26T07:13:19Z
dc.date.available2018-08-26T07:13:19Z
dc.date.issued2018
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/44932
dc.description.abstractBackground: Cancer is one of the main causes of death in the world. It has not yet been cured in an efficient manner and has remained a major challenge for current chemotherapy. Objective: This review summarizes the latest investigations regarding the possible application of phytosome complexes for cancer therapy, their formulation techniques, and mechanism of transportation through phytosome. Results: Nanotechnology opened a pioneer field in cancer therapy by modifying significant properties of drugs and their carriers. Nanotechnology utilizes various nanostructures to transport anti-cancer agents to the site of action. The greater stability of nanophytosomes is due to formation of chemical links between phospholipid molecules and phytoactive agents. Among several new drug delivery systems, phytosomes depict an advanced technology to deliver phytoactive compounds to the target site of action, and at present, several phytosome formulations are in clinical use. Conclusion: Potential anti-cancer properties of phytoconstituents are enhanced by phytosomal formulations.
dc.language.isoEnglish
dc.relation.ispartofCURRENT DRUG TARGETS
dc.subjectCancer
dc.subjectdrug delivery
dc.subjectnanocarrier
dc.subjectphospholipid
dc.subjectphytosome
dc.subjectanticancer agent
dc.titleNano-Phytosome: A Developing Platform for Herbal Anti-Cancer Agents in Cancer Therapy
dc.typeReview
dc.citation.volume19
dc.citation.issue2
dc.citation.spage170
dc.citation.epage180
dc.citation.indexWeb of science
dc.identifier.DOIhttps://doi.org/10.2174/1389450118666170508095250


فایلهای درون آیتم

فایلهاسایزفرمتنمایش

هیچ فایل مرتبطی وجود ندارد

این آیتم در مجموعه های زیر مشاهده می شود

نمایش پرونده ساده آیتم